The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Assertio (ASRT) one of those stocks right now? Let's take a ...

The average one-year price target for Assertio Holdings (NasdaqCM:ASRT) has been revised to $27.80 / share. This is a ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

Detailed price information for Assertio Therapeutics Inc (ASRT-Q) from The Globe and Mail including charting and trades.

Assertio Holdings is back in focus after its fair value estimate was reset from US$37.44 to US$21.33, a cut of roughly 43% that reflects a more cautious stance on the stock. Analysts are weighing this ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Detailed price information for Assertio Therapeutics Inc (ASRT-Q) from The Globe and Mail including charting and trades.

In this article we will analyze whether Assertio Holdings Inc. (NASDAQ:ASRT) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ...